Dedicated NAT screening for blood donation safety
PoET® System
Fully automated system
featuring on-board pooling
PoET® Kits
Comprehensive menu
Who we are
Strategically headquartered within the Frankfurt Biotechnology Innovation Center (FiZ) in Frankfurt am Main, Germany, we have been at the forefront of blood safety since our inception.
Founded in 2005 by blood donation centers of the German Red Cross, GFE was among the first companies to implement cutting-edge NAT technology for the early detection of HCV, HBV, and HIV in blood donor screening.
With our PoET® Instrument we offer an intuitive, fully automated system designed to enhance laboratory workflow.
We provide “ready-to-use” diagnostic kits, engineered for maximum reliability. By integrating multi-dye techniques and multiple gene targets, our assays ensure exceptional sensitivity and specificity.
GFE continues to evolve, offering optimal solutions to meet the increasing demands of modern laboratories:
- New PoET® Multiscreen assay (HCV, HBV, HIV-1/2): Streamlining detection by identifying multiple pathogens in a single run.
- PoET® Universal Positive Control: Ensuring faster control process in combination with the PoET Multiscreen assay.
- PoET® CMV: The only CMV assay dedicated for blood screening with high-precision detection for Cytomegalovirus.
Sales
Phone +49 69 400 5513-38
Email sales@gfeblut.de